Detail
| LncRNA Name | F11-AS1 |
| Synonyms | F11-AS1 |
| Region | GRCh38_4:186286094-186500997 Sequence |
| Ensembl | ENSG00000251165 |
| RefSeq | NR_033901 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | pancreatic ductal adenocarcinoma |
| ICD-0-3 | C25.3 M8500/3 |
| Methods | microarray, qPCR etc. |
| Sample | cell lines (SW1990, BxPC etc.) |
| Expression Pattern | down-regulated |
| Function Description | We selected two upregulated lncRNAs (LINC00152 and CASC9) that were reported to be upregulated in other cancers, and two mostly downregulated lncRNAs (LINC00226 and F11-AS1) for further validation in PDAC cell lines and the normal cell line HPDE. F11-AS1 was only downregulated in 6 cell lines compared with HPDE cells. |
| Pubmed ID | 28220683 |
| Year | 2017 |
| Title | Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma. |
| External Links |
| Links for F11-AS1 | GenBank HGNC lncrnadb Noncode |
| Links for pancreatic ductal adenocarcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.